Spruce Biosciences, Inc. (SPRB) PT Lowered to $9 at RBC Capital

March 15, 2022 6:30 AM EDT Send to a Friend

RBC Capital analyst Gregory Renza ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Spruce Biosciences, Inc. (SPRB) PT Lowered to $9 at RBC Capital

Member Login

Free News Feed